Pre-market · Oct 8, 8:20 am ET · After hours $16.42 0.00%
Open$16.44
Prev close$16.56
Day range$16.25 – $17.11
Volume915.6K
Market cap$1.09B
P/E (TTM)–
Dividend yield–
BCAX Stock News
Headlines matching Bicara Therapeutics or the BCAX ticker, most recent first.
JonesTrading Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $30Market news · 8 Sep 2026 · Direct mention
Stifel Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Cuts Target Price to $45NegativeMarket news · 14 Aug 2026 · Direct mention
Mizuho Securities Reaffirms Their Hold Rating on Bicara Therapeutics Inc. (BCAX)TipRanks · 13 Aug 2026 · Direct mention
Wedbush Reaffirms Their Buy Rating on Bicara Therapeutics Inc. (BCAX)TipRanks · 13 Aug 2026 · Direct mention
Analysts Are Bullish on Top NA Stocks: Veradermics, Incorporated (MANE), Bicara Therapeutics Inc. (BCAX)PositiveTipRanks · 12 Aug 2026 · Direct mention
Morgan Stanley Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $37Market news · 12 Aug 2026 · Direct mention
Analysts Conflicted on These NA Names: Bicara Therapeutics Inc. (BCAX), CoreWeave (CRWV) and Cardinal Infrastructure Group, Inc. (CDNL)TipRanks · 12 Aug 2026 · Direct mention
BofA Securities Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Announces Target Price $34Market news · 12 Aug 2026 · Direct mention
BTIG Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Raises Target Price to $39PositiveMarket news · 12 Aug 2026 · Direct mention
Analysts Offer Insights on NA Companies: Enhanced Group (ENHA), MNTN, Inc Class A (MNTN) and Bicara Therapeutics Inc. (BCAX)TipRanks · 12 Aug 2026 · Direct mention
Analysts Have Conflicting Sentiments on These NA Companies: Bending Spoons (BSP), EToro (ETOR) and Bicara Therapeutics Inc. (BCAX)TipRanks · 12 Aug 2026 · Direct mention
Analysts Offer Insights on NA Companies: Smithfield Foods (SFD), Bicara Therapeutics Inc. (BCAX) and Concentra Group Holdings Parent, Inc. (CON)TipRanks · 12 Aug 2026 · Direct mention
BTIG Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $28Market news · 28 Jul 2026 · Direct mention
Bicara Therapeutics Inc. (BCAX) Gets a Hold From Wells FargoTipRanks · 2 Jun 2026 · Direct mention
BofA Securities Maintains Bicara Therapeutics(BCAX.US) With Buy RatingMarket news · 2 Jun 2026 · Direct mention
Discussion
No comments yet — be the first to weigh in on BCAX.
No comments yet — be the first to weigh in on BCAX.